MIM Fertility is a spin‑off from the University of Warsaw, founded in 2019 by PhD Piotr Wygocki and Ula Sankowska. The company develops AI-driven medical-device solutions for reproductive medicine, with products EMBRYOAID and FOLLISCAN that assist experts in embryo assessment and ovarian follicle identification. Its mission is to create AI-as-a-medical-device solutions that improve diagnosis and treatment outcomes in infertility and raise the standard of IVF care. In December 2023 MIM Fertility raised $2.0 million in a seed round. The funding will be used to refine existing technologies, develop new functionalities, and expand the company's global presence. The company positions its solutions to support clinicians and improve IVF treatment outcomes.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Dec 2023